WS

William Souillard-Mandar

Exploring something new & investing | AI+neuro | MIT

New York, New York

Invests in

  • Min Investment:

    $100,000.00
  • Max Investment:

    $20,000,000.00
  • Target Investment:

    $3,000,000.00

Education

Work Experience

2019

  • Investor, Advisor, Consultant

    2019

    Multi-strategy investments, from public markets to select startups with a focus on AI, healthcare, manufacturing (a few favorites: Anduril, Electric Era, Commonwealth Fusion Systems, Naveris, Rarecells) Venture Partner at Remus Capital Advisor at Entrepreneur First for start-ups in NYC, Paris, London, and Bangalore I also serve as a hands-on consultant/advisor to some of the companies that I back

  • PHD Student

    2021

    On leave; ML research applied to bio, health; courses in ML, computational biology

  • Venture Partner

    2019

    We lead Seed-Series B rounds in technology companies. Focus on building, not betting.

2020 - 2023

  • Advisor

    2021 - 2023

  • VP, AI and Analytics

    2020 - 2021

    We are a digital health company that seeks to leverage advances in artificial intelligence, digital biomarkers, and phenotyping to revolutionize the way users - whether healthy individuals, patients, clinicians, caregivers or researchers - take ownership of their mental and brain health.

  • Founding VP of Artificial Intelligence and Analytics

    2015 - 2020

    Company Acquired 2020 DCT is a digital health company spun out of MIT with the first FDA-cleared AI-based cognitive testing platform based on the analysis of natural behavior. The DCT platform is currently deployed in dozen of countries for pharmaceutical clinical trials and research studies, with the goals of reducing the cost to screen patients for clinical trials, serving as a cognitive outcome measure to monitor change and drug efficacy, and improving our understanding of cognition. It is also available and reimbursable for clinician use in the United States to rapidly screen and monitor patient cognitive health.

  • Researcher

    2012 - 2015

    - Developed machine learning algorithms for understanding natural drawing behavior and detecting neurological disorders, with a focus on clinical interpretability of the system - Winner of the 2016 INFORMS Innovative Application of Analytics Award - Publication in Machine Learning Journal and presentations at NeurIPS and ICML

2014 - 2014

  • Algorithmic Trader

    2014 - 2014

2012 - 2012

  • Researcher

    2012 - 2012